Steel Grove Capital Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Steel Grove Capital Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$360K	Hold	2,272	–	–	0.03%	165
2026 Q1	$290K	Hold	2,272	–	–	0.03%	170
2025 Q4	$277K	Buy	+2,272	New	+$261K	0.03%	158
2025 Q2	–	Sell	-3,572	Closed	-$290K	–	192
2025 Q1	$290K	Sell	3,572 -2,400	-40%	-$215K	0.04%	138
2024 Q4	$538K	Sell	5,972 -750	-11%	-$72.7K	0.07%	108
2024 Q3	$662K	Hold	6,722	–	–	0.09%	103
2024 Q2	$623K	Sell	6,722 -1,610	-19%	-$144K	0.09%	107
2024 Q1	$791K	Sell	8,332 -2,601	-24%	-$241K	0.11%	101
2023 Q4	$976K	Sell	10,933 -3,749	-26%	-$278K	0.13%	74
2023 Q3	$1.07M	Buy	14,682 +6,210	+73%	+$496K	0.14%	86
2023 Q2	$705K	Buy	8,472 +650	+8%	+$54.4K	0.09%	96
2023 Q1	$596K	Buy	7,822 +5,400	+223%	+$448K	0.08%	104
2022 Q4	$201K	Buy	+2,422	New	+$196K	0.03%	167
2022 Q2	–	Sell	-150	Closed	-$13K	–	157
2022 Q1	$13K	Buy	150 +80	+114%	+$7.39K	﹤0.01%	155
2021 Q4	$8K	Buy	+70	New	+$8.44K	﹤0.01%	150

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Steel Grove Capital Advisors's XBI Position: Q2 2026 in Review

Steel Grove Capital Advisors held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 2,272 shares worth $360K. The position accounts for 0.03% of the portfolio, ranked #165.

Steel Grove Capital Advisors first reported a position in XBI in Q4 2021 and has held it in 15 quarters since. The position peaked at $1.07M in Q3 2023. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Steel Grove Capital Advisors held 2,272 shares of State Street SPDR S&P Biotech ETF worth $360K as of Q2 2026.
Steel Grove Capital Advisors left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.03% of Steel Grove Capital Advisors's portfolio in Q2 2026, its #165 holding.
Steel Grove Capital Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 15 quarters since.
Steel Grove Capital Advisors's State Street SPDR S&P Biotech ETF position peaked at $1.07M in Q3 2023.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Steel Grove Capital Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.